SUMMARY In 35 open chest anesthetized dogs coronary and aortic blood flow were measured with electromagnetic flowmeters while aortic and distal coronary blood pressure and an epicardial ECG were recorded. A fixed amount of stenosis (60-80%) was produced in the coronary artery by an externally applied plastic cylinder. In 24 of the 35 dogs the coronary blood flow showed cyclical reductions to near zero, with a sudden spontaneous return to near control levels. During reduced flow the epicardial ECG showed ST-segment depression suggestive of ischemia, and ventricular premature beats were often noted. Six animals died acutely during episodes of reduced flow.
MANY STUDIES OF MYOCARDIAL INFARCTION
AND SUDDEN DEATH from coronary heart disease have been reported. The significance of acute occlusive thrombi as a precipitating cause is widely debated.' 2 Acute coronary occlusion by thrombi were found in 21%' to 88%4 of those infarcted hearts examined at autopsy. These data vary with the investigative technique and material examined. In many patients with coronary artery disease and sudden death no acute thrombus or other mechanism for producing acute coronary insufficiency is demonstrated at post mortem examination and an episode of transient ischemia precipitating arrhythmia is often postulated.
Platelet aggregation is involved in the formation of arterial thrombi and is not prevented by coumarin or heparin anticoagulant therapy.5 Mechanical damage of platelets can induce platelet aggregation in vitro6 and thrombosis occurs in areas of turbulent flow.7 It has been postulated that the turbulent flow produced at the sites of atherosclerotic plaques may play a role in thrombus formation by inducing platelet aggregation.' It has also been postulated that sudden coronary death may result from platelet aggregates in the epicardial arteries of man.8 '9 We present experimental evidence here that a fixed stenosis in a narrowed coronary artery promotes periodic in vivo platelet aggregation which transiently increases obstruction and decreases coronary blood flow. The possible significance of these observations to coronary disease in man is discussed.
Material and Methods Thirty-five healthy adult mongrel dogs of both sexes were anesthetized with morphine sulfate (3 mg/kg) followed one hour later by sodium pentobarbital (30 mg/kg). Respiration was maintained using a positive pressure respirator, and the heart was exposed through a left thoracotomy at the fifth intercostal space in the usual fashion.
After 35 mg/kg of aspirin were given intravenously the cyclical reductions in coronary blood flow were abolished and the in vitro platelet aggregations were reduced from a control of 62.1 ± 15 units (Born technique) to an average of 23.7 ± 12 units.
Histologic sections of the narrowed coronary artery obtained when coronary flow was reduced show an amorphous mass in the lumen which was thought to be a platelet aggregate. Perhaps a similar process of platelet aggregation occurs in the stenosed coronary arteries in man, producing acute coronary obstruction, ischemia, and sudden death.
Electromagnetic flowprobes were placed on the ascending aorta and either the circumflex or anterior descending coronary artery or both. The vessel utilized was chosen to provide a long uniform segment, tying small side branches whenever necessary. A 23 gauge silastic catheter was placed in the distal coronary artery for pressure measurement using the method of Khouri and Gregg.'0 A 2-0 silk ligature was placed loosely around the coronary artery below the flowmeter to permit temporary complete occlusion for measuring the reactive hyperemic response, and for checking baseline stability ( fig. 1) .
A cardiac catheter was passed down the carotid artery, with its tip in the ascending aorta near the aortic valve, for blood pressure measurement. Two ECG leads were sutured to the epicardium in the areas supplied by the circumflex and left anterior descending coronary arteries, respectively, as shown in figure 1. Control aortic and coronary blood pressure and flow, and electrocardiograms were recorded on a Brush Gould direct writing recorder. In all cases, there was no measurable pressure gradient between the aorta and the distal coronary artery prior to narrowing of the coronary artery.
A plastic cylinder 2.5 mm in length, designed to produce a 60-80% narrowing of the vessel, was then placed around the coronary artery between the flowprobe and the coronary artery catheter ( fig. 1) stability. Blood flows, pressures, and ECGs were then monitored continuously for one hour. Thirty minutes after the partial obstruction was produced, and during the one hour continuous recording, a 20 ml sample of venous blood was drawn into a plastic syringe for platelet count and platelet aggregation studies.
At the end of the procedure the percent obstruction produced was determined as follows: The vessel was ligated, first distal and then proximally. It was then excised, fixed in 10% formalin, embedded in paraffin, and sectioned. Microscopic sections were stained with Carstairs platelet stain prior to examination. The percent reduction of lumen diameter was determined by measuring with a calibrated microscope eyepiece and averaging three diameters of the vessel immediately proximal to the site of the constrictor and three diameters of the narrowed vessel within the constricted area. The percent reduction in lumen diameter was then calculated in the following way:
proximal diameter -narrowed diameter proximal diameter X 100
All animals were studied in the same fashion initially. They were then subjected to three different protocols to clarify the results. Group I -(Heparin and Aspirin). After the one hour observation period, 1 mg/kg of heparin was given intravenously to 20 dogs and systemic and coronary flow, pressures, and ECGs were recorded continuously for 30 min. Then, 35 mg/kg of acetylsalicylic acid dissolved in 150 ml of saline was given intravenously over a 15 min period. The same parameters were then monitored continuously for 1 1/2 hours more. Forty-five minutes after the aspirin was given a second 20 ml venous blood sample was obtained for platelet aggregation studies.
Group II -(Aspirin Only). In ten dogs no heparin was given. After the 11/2 hour observation period 35 mg/kg of acetylsalicylic acid was given as described above, continued hemodynamic observations were made, and the second 20 ml sample of venous blood was drawn 45 min later for platelet aggregation studies.
Group III. In five more dogs prepared as described above and in which cyclical reductions in coronary blood flow were noted neither aspirin nor heparin was given. The animals were observed carefully and at a time when coronary flow had reached a low point, and as best as we could judge by observations of previous cycles at a time immediately prior to when the flow should suddenly rise back to the control level, the vessel was carefully ligated distally, then proximally and then excised and immediately placed in 10% buffered formalin. The section was processed and lumen diameter measured as previously described.
Platelet Aggregation Studies
The 20 ml of venous blood was drawn into a plastic syringe and diluted with one part 3.8% trisodium citrate to nine parts blood in a polystyrene tube. Platelet rich plasma (PRP) was obtained by centrifuging this mixture for 15 min at room temperature. If the platelet count in the PRP was above 300,000/mm,3 it was adjusted to that figure with autologous platelet poor plasma (PPP); if the count was less than 300,000/mm,3 the plasma was used unmodified. Aggregation studies were done by a modification of the method of Born12 in a Chrono-Log Platelet Aggregometer (Chrono-Log Corporation, Broomall, PA). Four-tenths ml PRP was placed at 37°C in a siliconized cuvette in the aggregometer with a siliconized stirring bar. The aggregometer was adjusted to give 10 units and 90 units readings on a Heath recorder with PPP and PRP respectively. One tenth ml of aggregating substance (ADP 50,O g/ml) was added and the change in light transmission measured to the point where the tracing reached a plateau or began to rise. The aggregation tendency of each test sample was then reported in units ranging from 10 to 90 units, higher numbers indicating a greater aggregation of platelets by ADP.
Results
There were cyclical reductions in coronary blood flow and distal coronary artery pressure in many of the dogs. An example of a reduction in coronary flow is shown in figure 2 , followed by spontaneous return to near control levels at point x. The circumflex coronary blood flow had decreased to near zero, and the circumflex epicardial ECG shows STsegment deviation suggestive of ischemia in panel C. Figure 3 shows cyclical decreases in mean coronary flow and distal coronary pressure followed by spontaneous recovery. This occurs in spite of a constant mean arterial blood pressure and cardiac output. Group II The average platelet aggregation was 60 + 7 before the aspirin alone (group II, part A) at a time when cyclical flow reductions were noted, and this decreased to 20 ± 5 after the aspirin was given, and when cyclical reductions in flow were abolished (table 2) . The other four dogs (group It, part B) had an average platelet aggregation of 42 ± 8 before the aspirin and did not show any cyclical reductions in coronary flow. After the aspirin alone was given, platelet aggregation decreased to 31 ± 7 units (table  2) . The average platelet counts did not differ significantly between group II and group 1. Group III. All five dogs in this group showed cyclical reductions in flow, and had hemodynamic data comparable to groups I and II. In all five vessels which were ligated during the low point of a cyclical flow reduction, microscopy showed platelet aggregates in the narrowed lumen, or in the area just distal to the obstruction when the section was stained with the Carstairs stain for platelets. A representative photomicrograph is shown in figure 4 . By contrast those vessels which were ligated after heparin and aspirin or aspirin alone, when there were no cyclical flow reductions and flow was near the normal range, did not show platelet aggregates in the narrowed lumen. The quality of the histologic sections was not good enough to determine if there was slight damage to the endothelium. However there was no evidence that the endothelium was grossly damaged by the encircling plastic cylinder.
Discussion
When the phenomenon of cyclic reduction in blood flow was observed in segments of partially but rigidly obstructed coronary arteries it was presumed to be due either to fibrin deposition in the constricted lumen of the coronary artery or to accumulation of platelets at the site of perturbation of flow. If the increased obstruction were produced by fibrin it should have been prevented by heparinization but this did not occur. The possibility that platelet aggregates were responsible for the reduction in flow is supported by No 3, SEPTEMBER 1976 flow, the pressure gradient across the constriction increases until it is sufficient to displace the platelet plug from the narrowed lumen. These platelets could then pass distally as a mass producing peripheral microemboli, or they could deaggregate as they moved downstream leaving no residue. Further experiments are planned to clarify this phenomenon.
The cause of the marked variability of platelet aggregability in these normal dogs needs further study. Surely it may be due in part to the plasma level of circulating catecholamines or lipids, both of which are known to affect platelet aggregation."9 Local anesthetics also inhibit in vitro platelet aggregation in man20 and many factors including general anesthesia may have affected the platelets of these dogs. A survey of the literature has shown a clear relation between many coronary risk factors and increased platelet aggregability in man. It has been shown that cigarette smoking21' 22 hyperbetalipoproteinemia23' 24 diabetes mellitus25 and hyperuricemia with gout26 all increase in vitro platelet aggregation in man in response to standard stimuli. In addition, patients with elevated catecholamines such as in hypertension27 and coronary prone behavior pattern28 would be expected to be at greater risk of sudden death since catecholamines enhance human platelet aggregation. 29 These relationships are under investigation in our laboratory utilizing the present model in the hope that their significance in coronary disease may be elucidated.
